To evaluate the effectiveness of the SEE program in improving medication adherence and reducing glaucoma-related distress compared to standard education.
Key Findings:
SEE group showed significantly higher electronically monitored adherence (77.6%) compared to controls (58.0%).
54.9% of SEE participants achieved at least 80% adherence versus 23.7% of controls.
The intervention led to a significant reduction in glaucoma-related distress, particularly in emotional burden and regimen-related distress.
Interpretation:
The SEE program demonstrates that personalized, motivational interviewing-based coaching can effectively enhance medication adherence and alleviate distress in glaucoma patients.
Limitations:
The study was limited to a specific population from two health systems, which may affect generalizability.
Potential biases in self-reported adherence measures.
Conclusion:
The SEE program is a promising approach to improve adherence and reduce distress in glaucoma patients, warranting further evaluation in broader settings.
